REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
31/01/2026
Voltar para busca
Dado oficial do USPTO
DR NATURAL HEALING
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
DR NATURAL HEALING
ST13
US500000087028756Classe
5
Pedido
87028756
Registro
5132112
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
01/02/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
07/05/2016
Data de registro
31/01/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/06/2023
Última transação
01/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
701
Cadastro oficial
Principal Register
Primeiro uso
21/12/2014
Primeiro uso no comércio
21/12/2014
Código do desenho
4
Tipo de titular
03
Localização do titular
Milford, DE
Examinador
CALLOWAY, CHRISTINA DENISE
Unidade examinadora
N40
Localização atual
TMO LAW OFFICE 122
Titulares e representantes
Titulares
DrNaturalHealing, Inc.
Representantes
DrNaturalHealing, Inc.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting sensory organs; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for wounds; Pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparationsanticoagulants; Pharmaceutical preparationsantidepressants; Pharmaceutical preparationsantivirals; Pharmaceutical preparationsappetite suppressants; Pharmaceutical preparationsinjectable contraceptives; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticalsanti-infectives; Pharmaceuticalslipid lowering agents; Aerosol dispensers for medical use sold filled with bronchodilators; Antibacterial pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of fine powder that facilitate the delivery of pharmaceutical preparations; Eucalyptus for pharmaceutical purposes; Homeopathic pharmaceuticals for use in the treatment of cold-flu; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with Epinephrine; Menthol for pharmaceutical purposes; Mint for pharmaceutical purposes; Royal jelly for pharmaceutical purposes; Stick liquorice for pharmaceutical purposes; all the foregoing comprised of natural ingredients
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
17/06/2023
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
17/06/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
17/06/2023
ES8R
TEAS SECTION 8 RECEIVED
23/12/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
31/01/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
31/01/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/11/2016
PUBO
PUBLISHED FOR OPPOSITION
15/11/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/10/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/10/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/08/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/08/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/08/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
29/08/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
29/08/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
29/08/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
29/08/2016
DOCK
ASSIGNED TO EXAMINER
23/08/2016
MPMK
NOTICE OF PSEUDO MARK E-MAILED
12/05/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/05/2016
NWAP
NEW APPLICATION ENTERED
11/05/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DR NATURAL HEALING ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.